"It's going to make a big play in reducing the incidences of obesity and therefore diabetes and therefore the long-term complications associated with this condition." Despite this, there's still questions around whether generics will stack up to Novo Nordisk's brand name version
"The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men" (PDF)
Youll need to monitor your condition frequently once you start taking Wegovy
The Lancet Diabetes & Endocrinology , 9(7), 455-467
Monitoring focuses on glucose trends, kidney/liver context, lipids, heart rate, hydration, and GI symptom burden